Literature DB >> 19447676

New insights into the regulation of human B-cell differentiation.

Heike Schmidlin1, Sean A Diehl, Bianca Blom.   

Abstract

B lymphocytes provide the cellular basis of the humoral immune response. All stages of this process, from B-cell activation to formation of germinal centers and differentiation into memory B cells or plasma cells, are influenced by extrinsic signals and controlled by transcriptional regulation. Compared to naïve B cells, memory B cells display a distinct expression profile, which allows for their rapid secondary responses. Indisputably, many B-cell malignancies result from aberrations in the circuitry controlling B-cell function, particularly during the germinal centre (GC) reaction. Here, we review new insights into memory B-cell subtypes, recent literature on transcription factors regulating human B-cell differentiation and further evidence for B-cell lymphomagenesis emanating from errors during GC cell reactions.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19447676      PMCID: PMC2792751          DOI: 10.1016/j.it.2009.03.008

Source DB:  PubMed          Journal:  Trends Immunol        ISSN: 1471-4906            Impact factor:   16.687


  108 in total

Review 1.  ETS transcription factors and their emerging roles in human cancer.

Authors:  Arun Seth; Dennis K Watson
Journal:  Eur J Cancer       Date:  2005-10-06       Impact factor: 9.162

2.  IL-21 induces differentiation of human naive and memory B cells into antibody-secreting plasma cells.

Authors:  Rachel Ettinger; Gary P Sims; Anna-Marie Fairhurst; Rachel Robbins; Yong Sing da Silva; Rosanne Spolski; Warren J Leonard; Peter E Lipsky
Journal:  J Immunol       Date:  2005-12-15       Impact factor: 5.422

3.  MicroRNA expression profiles classify human cancers.

Authors:  Jun Lu; Gad Getz; Eric A Miska; Ezequiel Alvarez-Saavedra; Justin Lamb; David Peck; Alejandro Sweet-Cordero; Benjamin L Ebert; Raymond H Mak; Adolfo A Ferrando; James R Downing; Tyler Jacks; H Robert Horvitz; Todd R Golub
Journal:  Nature       Date:  2005-06-09       Impact factor: 49.962

4.  Deregulated BCL6 expression recapitulates the pathogenesis of human diffuse large B cell lymphomas in mice.

Authors:  Giorgio Cattoretti; Laura Pasqualucci; Gianna Ballon; Wayne Tam; Subhadra V Nandula; Qiong Shen; Tongwei Mo; Vundavalli V Murty; Riccardo Dalla-Favera
Journal:  Cancer Cell       Date:  2005-05       Impact factor: 31.743

5.  STAT3 is essential for Hodgkin lymphoma cell proliferation and is a target of tyrphostin AG17 which confers sensitization for apoptosis.

Authors:  U Holtick; M Vockerodt; D Pinkert; N Schoof; B Stürzenhofecker; N Kussebi; K Lauber; S Wesselborg; D Löffler; F Horn; L Trümper; D Kube
Journal:  Leukemia       Date:  2005-06       Impact factor: 11.528

6.  Differentiation stage-specific expression of microRNAs in B lymphocytes and diffuse large B-cell lymphomas.

Authors:  Raquel Malumbres; Kristopher A Sarosiek; Elena Cubedo; Jose W Ruiz; Xiaoyu Jiang; Randy D Gascoyne; Robert Tibshirani; Izidore S Lossos
Journal:  Blood       Date:  2008-12-01       Impact factor: 22.113

7.  Patterns of microRNA expression characterize stages of human B-cell differentiation.

Authors:  Jenny Zhang; Dereje D Jima; Cassandra Jacobs; Randy Fischer; Eva Gottwein; Grace Huang; Patricia L Lugar; Anand S Lagoo; David A Rizzieri; Daphne R Friedman; J Brice Weinberg; Peter E Lipsky; Sandeep S Dave
Journal:  Blood       Date:  2009-02-06       Impact factor: 22.113

8.  MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis.

Authors:  Flavia Pichiorri; Sung-Suk Suh; Marco Ladetto; Michael Kuehl; Tiziana Palumbo; Daniela Drandi; Cristian Taccioli; Nicola Zanesi; Hansjuerg Alder; John P Hagan; Reinhold Munker; Stefano Volinia; Mario Boccadoro; Ramiro Garzon; Antonio Palumbo; Rami I Aqeilan; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-26       Impact factor: 11.205

9.  Expression of the immunoregulatory molecule FcRH4 defines a distinctive tissue-based population of memory B cells.

Authors:  Götz R A Ehrhardt; Joyce T Hsu; Lanier Gartland; Chuen-Miin Leu; Shuangyin Zhang; Randall S Davis; Max D Cooper
Journal:  J Exp Med       Date:  2005-09-12       Impact factor: 14.307

10.  T cell-independent development and induction of somatic hypermutation in human IgM+ IgD+ CD27+ B cells.

Authors:  Ferenc A Scheeren; Maho Nagasawa; Kees Weijer; Tom Cupedo; Jörg Kirberg; Nicolas Legrand; Hergen Spits
Journal:  J Exp Med       Date:  2008-08-11       Impact factor: 14.307

View more
  30 in total

1.  Oncogenically active MYD88 mutations in human lymphoma.

Authors:  Vu N Ngo; Ryan M Young; Roland Schmitz; Sameer Jhavar; Wenming Xiao; Kian-Huat Lim; Holger Kohlhammer; Weihong Xu; Yandan Yang; Hong Zhao; Arthur L Shaffer; Paul Romesser; George Wright; John Powell; Andreas Rosenwald; Hans Konrad Muller-Hermelink; German Ott; Randy D Gascoyne; Joseph M Connors; Lisa M Rimsza; Elias Campo; Elaine S Jaffe; Jan Delabie; Erlend B Smeland; Richard I Fisher; Rita M Braziel; Raymond R Tubbs; J R Cook; Denny D Weisenburger; Wing C Chan; Louis M Staudt
Journal:  Nature       Date:  2010-12-22       Impact factor: 49.962

Review 2.  Overview of the immune response.

Authors:  David D Chaplin
Journal:  J Allergy Clin Immunol       Date:  2010-02       Impact factor: 10.793

3.  Signatures of murine B-cell development implicate Yy1 as a regulator of the germinal center-specific program.

Authors:  Michael R Green; Stefano Monti; Riccardo Dalla-Favera; Laura Pasqualucci; Nicole C Walsh; Marc Schmidt-Supprian; Jeffery L Kutok; Scott J Rodig; Donna S Neuberg; Klaus Rajewsky; Todd R Golub; Frederick W Alt; Margaret A Shipp; John P Manis
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-31       Impact factor: 11.205

4.  2,3,7,8-Tetrachlorodibenzo-p-dioxin-mediated disruption of the CD40 ligand-induced activation of primary human B cells.

Authors:  Haitian Lu; Robert B Crawford; Barbara L F Kaplan; Norbert E Kaminski
Journal:  Toxicol Appl Pharmacol       Date:  2011-07-21       Impact factor: 4.219

Review 5.  Original Antigenic Sin Response to RNA Viruses and Antiviral Immunity.

Authors:  Mee Sook Park; Jin Il Kim; Sehee Park; Ilseob Lee; Man-Seong Park
Journal:  Immune Netw       Date:  2016-10-25       Impact factor: 6.303

6.  The Plasmodium falciparum-specific human memory B cell compartment expands gradually with repeated malaria infections.

Authors:  Greta E Weiss; Boubacar Traore; Kassoum Kayentao; Aissata Ongoiba; Safiatou Doumbo; Didier Doumtabe; Younoussou Kone; Seydou Dia; Agnes Guindo; Abdramane Traore; Chiung-Yu Huang; Kazutoyo Miura; Marko Mircetic; Shanping Li; Amy Baughman; David L Narum; Louis H Miller; Ogobara K Doumbo; Susan K Pierce; Peter D Crompton
Journal:  PLoS Pathog       Date:  2010-05-20       Impact factor: 6.823

7.  Extensive co-operation between the Epstein-Barr virus EBNA3 proteins in the manipulation of host gene expression and epigenetic chromatin modification.

Authors:  Robert E White; Ian J Groves; Ernest Turro; Jade Yee; Elisabeth Kremmer; Martin J Allday
Journal:  PLoS One       Date:  2010-11-15       Impact factor: 3.240

8.  Peroxisome proliferator-activated receptor γ B cell-specific-deficient mice have an impaired antibody response.

Authors:  Sesquile Ramon; Simona Bancos; Thomas H Thatcher; Thomas I Murant; Safiehkhatoon Moshkani; Julie M Sahler; Andrea Bottaro; Patricia J Sime; Richard P Phipps
Journal:  J Immunol       Date:  2012-10-05       Impact factor: 5.422

9.  Genetic variants in toll-like receptor 2 (TLR2), TLR4, TLR9, and FCγ receptor II are associated with antibody response to quadrivalent meningococcal conjugate vaccine in HIV-infected youth.

Authors:  Stephen A Spector; Min Qin; Jorge Lujan-Zilbermann; Kumud K Singh; Meredith G Warshaw; Paige L Williams; Patrick Jean-Philippe; Terence Fenton; George K Siberry
Journal:  Clin Vaccine Immunol       Date:  2013-04-17

Review 10.  Emerging roles for protein S-palmitoylation in immunity from chemical proteomics.

Authors:  Jacob S Yount; Mingzi M Zhang; Howard C Hang
Journal:  Curr Opin Chem Biol       Date:  2013-01-14       Impact factor: 8.822

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.